Just when many people thought COVID had faded into the background, a new variant is beginning to raise fresh questions among scientists.
Nicknamed “Cicada,” this strain appears to have been lying low for some time, only to reemerge in multiple regions of the world. Experts say the unusual behavior behind the name is no coincidence:
like the insect, the virus seemed to remain hidden before suddenly appearing in ways that demand attention. Researchers are now closely monitoring the situation to determine whether this variant could spread more easily or partially evade existing immunity.
What We Know So Far About the New COVID Strain Nicknamed “Cicada”
The strain, identified as BA.3.2 in scientific reports, is drawing attention due to the number of changes observed in its genome, particularly in the spike protein. The spike protein is a critical component of the virus, allowing it to attach to and enter human cells.
Mutations in this region can influence transmission rates, immune response, and how well vaccines protect against infection. While viruses mutate naturally over time, BA.3.2 is unusual because it appears to carry more mutations than most circulating subvariants.
Experts point out that these genetic changes are what make BA.3.2 noteworthy—but they also caution against drawing immediate conclusions. Viruses can accumulate numerous mutations without necessarily becoming more dangerous or widespread. What truly matters is how a variant behaves in real-world populations: whether it spreads faster, causes more severe disease, or challenges existing immunity.
The nickname “Cicada” comes from the behavior of the insect known for remaining underground for years before emerging in large numbers.
Similarly, this COVID variant was first detected in South Africa in 2024 but initially remained at low levels and largely unnoticed. It stayed in the background while other variants circulated more visibly, only to reappear recently in multiple regions, including parts of Europe, Africa, and the United States. While detection does not automatically indicate a major surge, it highlights the importance of continued monitoring and public health surveillance.
Health authorities report that BA.3.2 has been observed in over 20 countries, though it currently accounts for a small fraction of overall COVID cases. In some European regions, the variant is making up a more noticeable share of infections, prompting closer observation.
Researchers are particularly focused on the spike protein, which reportedly carries between 70 and 75 mutations in this strain. This is a significant number, raising questions about potential immune escape or altered transmissibility, but scientists emphasize that laboratory findings do not always translate into real-world risk.
So far, there is no evidence to suggest that BA.3.2 causes more severe illness than other recent COVID strains. Hospitalization and death rates have not shown an uptick directly attributable to this variant.
Public health officials stress that while the virus may spread more efficiently or partially evade immune defenses, current vaccines remain a critical tool in preventing severe outcomes. Vaccine effectiveness against hospitalization and complications has remained high throughout the pandemic, even as new variants emerged.
This is an important distinction: the presence of numerous mutations does not automatically mean increased danger. History has shown that some variants rise quickly and then fade, while others remain present at low levels without causing major disruption. The key question is whether a variant changes the actual health risk in meaningful ways.
Public health experts are continuing to collect data on case numbers, hospitalization trends, and vaccine performance against BA.3.2. This cautious approach allows authorities to provide guidance based on evidence rather than speculation.
For individuals, the recommended response remains straightforward: stay up to date on booster guidance, practice common-sense precautions during local outbreaks, and be aware of symptoms. These steps remain effective regardless of the specific variant circulating.
The emergence of “Cicada” serves as a reminder that COVID has not disappeared. Even as the acute emergency phase of the pandemic recedes from memory, the virus continues to evolve quietly in the background. Most mutations are minor, but occasionally a variant emerges that warrants closer scrutiny. Careful monitoring and transparent communication allow public health agencies to respond quickly and prevent unforeseen surges.
Conclusion
The COVID variant nicknamed “Cicada” has drawn scientific interest because of its unusual genetic profile and reappearance across multiple countries. While its numerous mutations are noteworthy, there is currently no evidence that it causes more severe illness than other recent variants.
Health experts continue to emphasize that vaccines remain effective in preventing serious disease, and the best response for the public is awareness, not panic. As researchers gather more data, ongoing surveillance and evidence-based guidance will continue to shape public health strategies, ensuring communities remain prepared without overreacting.